Updated:
Eli Lilly Group Pension Plan
Eli Lilly Group Pension Plan operates as the UK defined-benefit vehicle for Eli Lilly and Company, the Indianapolis-headquartered pharmaceutical firm.
Eli Lilly Group Pension Plan
Eli Lilly Group Pension Plan operates as the UK defined-benefit vehicle for Eli Lilly and Company, the Indianapolis-headquartered pharmaceutical firm. The plan is governed by Eli Lilly Group Pension Trustees Ltd, a dedicated corporate trustee entity that separates scheme oversight from the parent company's commercial operations. Susan Ridlen served as Chief Investment Officer until 2025, leading the plan's investment strategy across multiple market cycles. The plan deploys capital across traditional institutional asset classes, with an allocation shaped by pension-liability matching requirements. Core exposures include investment-grade fixed income, inflation-linked gilts, and global equities, with additional allocations to private credit and real assets for yield enhancement. The plan has historically participated in annuity buy-in transactions — a liability-hedging tool common among maturing UK defined-benefit schemes — including a recorded annuitization under the "Lilly Lifestyle" vehicle. Geographic exposure concentrates in the UK and developed Europe, with selective diversification into North American and Asian markets through commingled fund structures. As a corporate pension scheme, the plan's scale is determined by the size of Eli Lilly's UK workforce and the associated benefit obligations. The trustee board, operating at arm's length from Eli Lilly's treasury function, oversees actuarial valuations and funding-level negotiations with the sponsor. In 2025, the plan underwent a leadership transition as Susan Ridlen retired from the CIO role, marking a succession milestone for the scheme's investment governance. The appointment of her successor — not yet publicly disclosed — will set the plan's strategic direction through the next funding cycle. The plan's structural differentiator is its position as a corporate-defined-benefit scheme inside a fully funded multinational sponsor — a configuration that gives it access to institutional-level investment management while remaining legally segregated from Eli Lilly's balance sheet. Unlike pooled local-government pension schemes or independent master trusts, the plan operates as a single-sponsor entity, giving trustees direct influence over contribution rates and benefit design. This governance model allows the plan to pursue a patient, low-turnover investment strategy without the peer-pressure dynamics that shape multi-employer or local-authority pools.
General information
Firm type
Pension Fund
Location
Region
Europe
Country
United Kingdom
City
Hampshire
Corporate office
Hampshire, United Kingdom
Principals
Susan Ridlen
Former Chief Investment Officer
Frequently asked questions
Who oversees investment decisions at the Eli Lilly Group Pension Plan?
Investment oversight rests with the trustee board of Eli Lilly Group Pension Trustees Ltd, the dedicated corporate trustee entity for the UK scheme. Day-to-day portfolio management was historically led by the Chief Investment Officer — a role held by Susan Ridlen until her 2025 retirement. The trustees operate independently from Eli Lilly's corporate treasury, with a fiduciary duty to plan beneficiaries.
How is the plan's investment strategy shaped by its defined-benefit structure?
As a mature defined-benefit scheme, the plan prioritizes liability-driven investment strategies aimed at matching the duration and inflation sensitivity of its pension obligations. This typically results in heavy allocations to long-dated government bonds, inflation-linked gilts, and annuity buy-in contracts. Growth assets like equities and alternatives play a supporting role, sized to close funding gaps without introducing excessive surplus volatility.
What is the "Lilly Lifestyle" annuity vehicle?
Lilly Lifestyle - Annuity is a recorded annuity buy-in structure associated with the UK pension plan. These arrangements transfer a portion of the plan's defined-benefit liabilities to an insurance company in exchange for a bulk-premium payment, reducing longevity and investment risk on the sponsoring employer's balance sheet. Such transactions are common among UK corporate schemes seeking to de-risk as they mature.
How does the plan interact with Eli Lilly and Company's corporate balance sheet?
The pension plan is legally segregated from Eli Lilly's operating company, with assets held in trust solely for the benefit of plan members. The sponsor, Eli Lilly and Company, negotiates contribution rates with trustees during triennial actuarial valuations. The trust structure ensures that pension assets would be protected in any insolvency scenario at the sponsor level.
Where does the plan's investment management sit geographically?
The plan is administered from the United Kingdom, where Eli Lilly's British subsidiary maintains operations. Investment mandates are executed through external fund managers and pooled institutional vehicles, with trustees retaining asset-allocation and manager-selection authority. The scheme does not operate as a direct-investing institution.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: